fig2

From: Lycopene treatment stalls the onset of experimentally induced hepatocellular carcinoma: a radioisotopic, physiological and biochemical analysis

Lycopene treatment stalls the onset of experimentally induced hepatocellular carcinoma: a radioisotopic, physiological and biochemical analysis

Figure 2. Effect of LycT and/or NDEA on hepatic T_peak (A) and T_{1/2 peak} (B) of ^99mTc-labeled Mebrofenin in various treatment groups. Values are expressed as mean ± SD (n = 5) and analyzed by one-way analysis of variance followed by post hoc test. ^aP ≤ 0.001 and ^a1P ≤ 0.01, significant as compared to control group; ^bP ≤ 0.001, significant as compared to NDEA group; ^cP ≤ 0.001 and ^c2P ≤ 0.05, significant as compared to LycT group. NDEA: N-nitrosodiethylamine; LycT: lycopene enriched tomato extract